Updated Jul 16, 2026
Campbell David Alan has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.04M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-11 | JANX | Janux Therapeutics, Inc. | M — Option exercise | 7.0K | $4.21 | $29K |
| 2024-12-27 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 25.0K | $56.19 | $1.40M |
| 2024-12-03 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 15.0K | $67.00 | $1.00M |
| 2024-11-27 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 6.7K | $52.04 | $350K |
| 2024-11-27 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 18.3K | $51.43 | $940K |
| 2024-10-30 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 11.1K | $53.94 | $599K |
| 2024-10-30 | JANX | Janux Therapeutics, Inc. | S — Open-market sale [10b5-1] | 13.9K | $53.22 | $740K |
Campbell David Alan is a corporate insider — currently tracked as Insider of Janux Therapeutics, Inc. (JANX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($5.04M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Campbell David Alan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.